The perfect pair for mastitis prevention

  1. Ontario Dairy Farm Accounting Project. Annual Report 2018. A co-operative project of Canadian Dairy Commission Dairy Farmers of Ontario. Released July 2019.
  2. Aghamohammadi M, Haine D, Kelton DF, et al. Herd-level mastitis-associated costs on Canadian dairy farms. Frontiers in Veterinary Science 2018;5:100.
  3. Dufour S, Wellemans V, Roy J, et al. Non-antimicrobial approaches at drying-off for treating and preventing intramammary infectionsin dairy cows. Part 1. Meta-analyses of efficacy of using an internal teat sealant without a concomitant antimicrobial treatment. Animal Health Research Reviews 2019;1-12.
  4. Baillargeon P, LeBlanc SJ. Clinical and economic effects of an internal teat sealant at dry-off on the incidence of clinical mastitis in early lactation. Bovine Pract 2010;(44):1-11.
  5. Olde Riekerink RGM, Barkema HW, Kelton DF, Scholl DT. 2008. Incidence Rate of Clinical Mastitis on Canadian Dairy Farms. J Dairy Sci. 91:1366-1377.
  6. Gonzalez RN, Cullor JS, Jasper DE, et al. 1989. Prevention of clinical coliform mastitis by a mutant Escherichia coli vaccine. Can J Vet Res. 53(3):301-305.
  7. Hogan JS, Smith KL, Todhunter DA, Schoenberger PS. 1992. Field trial to determine efficacy of an Escherichia coli J5 mastitis vaccine.J Dairy Sci. 75:78-84.
  8. Gonzalez RN, Wilson D, Muhammed H. 1996. A placebo-controlled trial of an Escherichia coli J5 bacterin and the ribotyping-based assessment of coliform bacteria diversity on a dairy farm. Proc. 19th World Buiatrics Congress, Edinburgh:277-280.
  9. Alaniz GR, Meinert TR, Loveland WJ, et al. 2013. Evaluation of Escherichia coli Bacterin, J‑5 Strain, as an Aid in the Control of Clinical Signs Associated with E. coli Mastitis in Dairy Cows. Proc. 52nd National Mastitis Council annual meeting, San Diego:199-200.